Association of Being Accompanied at Medical Consultation and Having Memory Complaints With Cognitive Impairment in Elderly Brazilian Outpatients.

BACKGROUND: The usefulness of both the presence of a companion at the medical consultation and patient's cognitive complaints as selection strategies for performing a dementia evaluation is still unclear. OBJECTIVES: To estimate the association of elderly patients being accompanied during medical visits and patient's memory complaint with objective cognitive impairment. METHODS: We included elderly outpatients awaiting medical consultations in 3 non-neurological medical specialties. Demographic and Mini-Mental State Examination were collected. Patients' memory complaints were evaluated with a single question to both patients and companions. RESULTS: Five hundred ninety-three elderly patients were included in the study with 64.6% female and median (interquartile range) age 73 (68-78), 4 (2-6) years of education. Of these, 242 patients were accompanied and 62.6% presented memory complaints. The median (interquartile range) Mini-Mental State Examination scores were significantly lower in patients accompanied and in those with memory complaints. In a logistic regression model, age, education, memory complaint, and presence of companion were associated with cognitive impairment. In the model including only accompanied patients, only age and companion memory complaints were associated with objective cognitive impairment. CONCLUSIONS: The presence of a companion during a clinical consultation and patients' memory complaints are both synergistically associated with objective cognitive impairment.

Dementia in Latin America: Paving the way toward a regional action plan.

Across Latin American and Caribbean countries (LACs), the fight against dementia faces pressing challenges, such as heterogeneity, diversity, political instability, and socioeconomic disparities. These can be addressed more effectively in a collaborative setting that fosters open exchange of knowledge. In this work, the Latin American and Caribbean Consortium on Dementia (LAC-CD) proposes an agenda for integration to deliver a Knowledge to Action Framework (KtAF). First, we summarize evidence-based strategies (epidemiology, genetics, biomarkers, clinical trials, nonpharmacological interventions, networking, and translational research) and align them to current global strategies to translate regional knowledge into transformative actions. Then we characterize key sources of complexity (genetic isolates, admixture in populations, environmental factors, and barriers to effective interventions), map them to the above challenges, and provide the basic mosaics of knowledge toward a KtAF. Finally, we describe strategies supporting the knowledge creation stage that underpins the translational impact of KtAF.

Clinicogenetic lessons from 370 patients with autosomal recessive limb-girdle muscular dystrophy.

Limb-girdle muscular dystrophies (LGMD) are a group of genetically heterogeneous disorders characterized by predominantly proximal muscle weakness. We aimed to characterize epidemiological, clinical and molecular data of patients with autosomal recessive LGMD2/LGMD-R in Brazil. A multicenter historical cohort study was performed at 13 centers, in which index cases and their affected relatives' data from consecutive families with genetic or pathological diagnosis of LGMD2/LGMD-R were reviewed from July 2017 to August 2018. Survival curves to major handicap for LGMD2A/LGMD-R1-calpain3-related, LGMD2B/LGMD-R2-dysferlin-related and sarcoglycanopathies were built and progressions according to sex and genotype were estimated. In 370 patients (305 families) with LGMD2/LGMD-R, most frequent subtypes were LGMD2A/LGMD-R1-calpain3-related and LGMD2B/LGMD-R2-dysferlin-related, each representing around 30% of families. Sarcoglycanopathies were the most frequent childhood-onset subtype, representing 21% of families. Five percent of families had LGMD2G/LGMD-R7-telethonin-related, an ultra-rare subtype worldwide. Females with LGMD2B/LGMD-R2-dysferlin-related had less severe progression to handicap than males and LGMD2A/LGMD-R1-calpain3-related patients with truncating variants had earlier disease onset and more severe progression to handicap than patients without truncating variants. We have provided paramount epidemiological data of LGMD2/LGMD-R in Brazil that might help on differential diagnosis, better patient care and guiding future collaborative clinical trials and natural history studies in the field.

The Use of the Clinical Dementia Rating Scale Sum of Boxes Scores in Detecting and Staging Cognitive Impairment/Dementia in Brazilian Patients With Low Educational Attainment.

The aim of this study was to evaluate the Clinical Dementia Rating Scale sum of the boxes (CDR-SB) diagnostic validity in detecting and staging cognitive impairment/dementia in a sample of Brazilian patients with amnestic mild cognitive impairment (aMCI), Alzheimer disease (AD), and vascular dementia (VD), of low educational attainment. Data were obtained from the Dementia Clinic of Hospital de Clínicas de Porto Alegre database and included 407 participants (115 healthy elderly, 41 aMCI, 165 AD, and 86 VD). Receiver operating characteristic curves were generated to detect best CDR-SB cutoffs. Average education was 4 years. A CDR-SB cutoff ≥0.5 was obtained to correctly identify MCI from normal controls (sensitivity of 100% and specificity of 98.3%). The cutoff ≥4.5 correctly identified aMCI from dementia altogether or separately (AD and VD) (sensitivity of 96.4% and specificity of 100%) in 96.9% of the individuals. Similar AUC was found for ≤4 and >4 years of education. The CDR-SB showed good clinical validity to detect and classify severity of cognitive impairment Brazilian patients with low educational attainment. Findings were similar to the original study carried out with higher educated individuals.

(Pre)diabetes, brain aging, and cognition.

Cognitive dysfunction and dementia have recently been proven to be common (and underrecognized) complications of diabetes mellitus (DM). In fact, several studies have evidenced that phenotypes associated with obesity and/or alterations on insulin homeostasis are at increased risk for developing cognitive decline and dementia, including not only vascular dementia, but also Alzheimer's disease (AD). These phenotypes include prediabetes, diabetes, and the metabolic syndrome. Both types 1 and 2 diabetes are also important risk factors for decreased performance in several neuropsychological functions. Chronic hyperglycemia and hyperinsulinemia primarily stimulates the formation of Advanced Glucose Endproducts (AGEs), which leads to an overproduction of Reactive Oxygen Species (ROS). Protein glycation and increased oxidative stress are the two main mechanisms involved in biological aging, both being also probably related to the etiopathogeny of AD. AD patients were found to have lower than normal cerebrospinal fluid levels of insulin. Besides its traditional glucoregulatory importance, insulin has significant neurothrophic properties in the brain. How can clinical hyperinsulinism be a risk factor for AD whereas lab experiments evidence insulin to be an important neurothrophic factor? These two apparent paradoxal findings may be reconciliated by evoking the concept of insulin resistance. Whereas insulin is clearly neurothrophic at moderate concentrations, too much insulin in the brain may be associated with reduced amyloid-beta (Abeta) clearance due to competition for their common and main depurative mechanism - the Insulin-Degrading Enzyme (IDE). Since IDE is much more selective for insulin than for Abeta, brain hyperinsulinism may deprive Abeta of its main clearance mechanism. Hyperglycemia and hyperinsulinemia seems to accelerate brain aging also by inducing tau hyperphosphorylation and amyloid oligomerization, as well as by leading to widespread brain microangiopathy. In fact, diabetes subjects are more prone to develop extense and earlier-than-usual leukoaraiosis (White Matter High-Intensity Lesions - WMHL). WMHL are usually present at different degrees in brain scans of elderly people. People with more advanced WMHL are at increased risk for executive dysfunction, cognitive impairment and dementia. Clinical phenotypes associated with insulin resistance possibly represent true clinical models for brain and systemic aging.

Increasing rational use of cholinesterase inhibitors for Alzheimer's disease in Brazil: public health strategy combining guideline with peer-review of prescriptions.

OBJECTIVES: Since 2002, the treatment with cholinesterase inhibitors (CHEIs) for Alzheimer's disease (AD) has been paid for by the public health system of the Brazilian Ministry of Health for any patient that fulfills clinical criteria established by an evidence-based guideline developed and published by the Ministry. The aim of this study was to evaluate compliance of prescription patterns to the national guideline for use of CHEIs' in the southern Brazilian state of Rio Grande do Sul. METHODS: We created a regional expert-committee reference center to review all prescriptions of CHEIs and to send feedback to physicians whenever prescriptions without compliance to the guideline were noted. One thousand three hundred ninety-nine (1,399) CHEI prescriptions presented to the public health system from 2005 to 2007 were evaluated by an expert team of neurologists and psychiatrists. Clinical history, performance on mental status screening by Mini Mental State Examination (MMSE), Clinical Dementia Rating scale (CDR), laboratory results, and neuroimaging findings were evaluated in relation to the adherence to the national guideline's recommendations. If the prescription was rejected because of lack of adherence to the criteria of the guideline, a written response was sent by the expert committee to physicians concerning the request. RESULTS: The majority of the requests (n = 1,044; 75 percent) did not meet the AD guideline's criteria, either for diagnosis or for treatment, and were not granted. A diagnostic mistake was evident in 64.3 percent of cases. Findings of vascular or Parkinson's dementia or severe AD were the main reasons for rejection. Rivastigmine was the most prescribed cholinesterase inhibitor, used in 86 percent of cases. Of note was the reduction in the number of CHEIs prescriptions in the years following this intervention. CONCLUSIONS: The public health strategy of using expert-review of prescriptions and their compliance to national guideline revealed a low rate of rational use of CHEIs for dementia. Such a strategy is relevant for protecting patients from unproven medical interventions and for reducing waste of resources.

Association among items from the self-report version of the Hamilton Depression Scale (Carroll Rating Scale) and respondents' sex.

The association among items of the self-reported version of the Hamilton Depression Scale (Carroll Rating Scale), answered according to a memory of a maximally disturbing event experienced, and respondents' sex was examined in a nonclinical sample of 320 college students, 164 women (M age=21.7 yr., SD=3.6) and 156 men (M age=23.5 yr., SD=5.8). An assessment of sex bias was also evaluated. Multiple regression analysis showed that statements regarding unhappiness, urge to cry, dizziness and faintness, and waking in the middle of the night were significantly associated with women. Removal of these items from the Carroll Rating Scale Total scores eliminated the sex differences in depression rates. Items that displayed significant sex bias were those regarding behavior and emotions commonly attributed to women within the general population.

Benchmarking matching pursuit to find sleep spindles.

The aim of this study is to evaluate performance of Matching Pursuit (MP) algorithm against visual analysis for automatic sleep spindle (SS) detection in a sample of sleep stages 2-4 and REM pertaining to nine healthy young subjects. MP-SS voltage, frequency and duration characteristics were investigated for the amplitude threshold (AT) that maximized yield between test sensitivity and specificity. Parameter distribution curves were also built for correctly detected (true positive) and false-positive events. For sleep stage 2, MP reached 80.6% sensitivity and specificity for an AT value of 58.8. For all stages together, 81.2% sensitivity and specificity were reached for an AT value of 46.6. Specificity curves were adequate for all stages; sensitivity was lower for S3+4. Sigma frequency range activity with atypical characteristics was detected within REM sleep. Prevalence indexes obtained with MP were much higher than visual prevalence indexes for all stages; similar voltage, frequency and duration distribution curves were obtained for true positive and false positive events. For this sample of young male healthy subjects, the free-ware MP algorithm showed satisfactory performance for SS detection in sleep stage 2 as reported earlier, acceptable performance in sleep stages 3+4, although with lowered sensitivity, and sigma frequency range activity within REM sleep that needs better understanding. Within NREM sleep, correspondence between the MP automatic and the visual method was supported.

Does previous presentation of verbal fluency tasks affect verb fluency performance?

BACKGROUND: Performance on the verb fluency (VF) task may be influenced by administration procedures and demographic factors of each population. OBJECTIVE: The aim of this study was to verify whether the previous administration of semantic and phonemic verbal fluency tasks can influence performance on VF; and to analyze the correlation of VF performance with education, age and type of errors in Brazilian healthy elderly. METHODS: Sixty-two participants were subdivided into experimental (semantic and the phonemic fluency tasks were administered before the VF) and control groups (VF only). The total score and the types of errors on the VF task were determined. Additional information was computed for the correlational analysis. RESULTS: VF performance did not differ statistically between experimental and control groups, but correlated positively with education and negatively with intrusions. CONCLUSION: The lack of influence of other verbal fluency tasks on performance of the VF task in elderly individuals allows the use of this order of administration. A strong influence of educational level on VF task performance reinforces the need for further studies in different populations.

INTRODUÇÃO: O desempenho na tarefa de fluência de verbos (FV) pode ser influenciado pelo modo de administração e por fatores sócio-demográficos de cada população. OBJETIVO: Este estudo teve como objetivo verificar se a administração prévia das tarefas de fluência verbal (fluência semântica e fonêmica) poderia influenciar no desempenho da FV, assim como analisar a correlação da FV com escolaridade, idade e tipos de erros em Brasileiros idosos saudáveis. MÉTODOS: essenta e dois participantes foram divididos em grupo experimental (fluências semântica e fonêmica foram aplicadas antes da FV) e em grupo controle (apenas a FV foi aplicada). O escore total e os tipos de erros da FV foram verificados. Informações adicionais foram consideradas para a análise de correlação. RESULTADOS: Não houve diferença estatisticamente significativa entre os grupos experimental e controle quanto ao desempenho da FV. A FV se correlacionou positivamente com a escolaridade e negativamente com as intrusões. CONCLUSÃO: A falta de influência de outras tarefas de fluência verbal no desempenho da FV em indivíduos idosos permite o uso dessa ordem de administração. Uma forte influência da escolaridade sobre o desempenho da FV reforça a necessidade de estudos em diferentes populações.

Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01).

OBJECTIVE: To investigate the effects of galantamine on the performance of patients with mild to moderate Alzheimer's disease (AD) in a computerized neuropsychological test battery (CNTB). METHOD: Thirty-three patients with probable AD were treated with galantamine for three months and evaluated in a prospective, open-label, multi-center study. The CNTB and the ADAS-Cog were administered at baseline and after 12 weeks. The CNTB includes reaction time tests to evaluate attention, implicit and episodic memory for faces and words. Statistical comparisons were performed between the results in week 12 versus baseline. Patients who did not reach the therapeutic doses were excluded from the efficacy analysis. RESULTS: Four patients (12.1%) were excluded from the analysis either because of treatment discontinuation (n=3) or because a therapeutic dose was not reached (n=1). The remaining 29 patients were treated with doses of 24 mg/day (n=22) and 16 mg/day (n=7). After 12 weeks, significant reductions in reaction time were seen in the test of episodic memory for faces (p=0.023) and in the test of two-choice reaction time (p=0.039) of the CNTB. CONCLUSION: Treatment with galantamine produced improvement in computerized tests of attention and episodic memory after 12 weeks, leading to statistically significant reduction in the reaction times.

Schizophrenia in males of cognitive performance: discriminative and diagnostic values.

OBJECTIVE: To evaluate the discriminative and diagnostic values of neuropsychological tests for identifying schizophrenia patients. METHODS: A cross-sectional study with 36 male schizophrenia outpatients and 72 healthy matched volunteers was carried out. Participants underwent the following neuropsychological tests: Wisconsin Card Sorting test, Verbal Fluency, Stroop test, Mini Mental State Examination, and Spatial Recognition Span. Sensitivity and specificity estimated the diagnostic value of tests with cutoffs obtained using Receiver Operating Characteristic curves. The latent class model (diagnosis of schizophrenia) was used as gold standard. RESULTS: Although patients presented lower scores in most tests, the highest canonical function for the discriminant analysis was 0.57 (Verbal Fluency M). The best sensitivity and specificity were obtained in the Verbal Fluency M test (75 and 65, respectively). CONCLUSIONS: The neuropsychological tests showed moderate diagnostic value for the identification of schizophrenia patients. These findings suggested that the cognitive impairment measured by these tests might not be homogeneous among schizophrenia patients.

The Basis and Applications of the Action Fluency and Action Naming Tasks.

The Action Fluency (AF) and Action Naming (AN) are different tasks involving verb generation. Evidence indicates that verb tasks yield different information from that obtained with nouns. OBJECTIVE: This study aimed to analyze the information available in the scientific literature on the mechanism and clinical application of these tasks. METHODS: We carried out a systematic review of the literature and the findings were presented according to clinical studies and neuroimaging studies, and to the task in question. RESULTS: The literature contained a variety of relevant studies with different objectives, methodologies and populations. After the analysis (exclusion criteria) of the studies obtained by the search terms, only 40 studies were included in this review. CONCLUSION: It was possible to conclude that AF and AN involve different brain processes, and although recruiting frontal areas and circuits, other areas are also critical. These tasks may be useful for differentiating Primary Progressive Aphasias; AF might represent a new measure of executive function; finally, both these tests can be used to provide a better understanding of cognitive processes and certain diseases.

A Fluência de Ações (FA) e a Nomeação de Ações (NA) são diferentes tarefas que exigem geração de verbos. Evidências indicam que tarefas que utilizam verbos fornecem informações diferentes daquelas que utilizam substantivos. OBJETIVO: Este estudo objetivou analisar a informação disponível na literatura científica sobre mecanismos e aplicações clínicas destas tarefas. MÉTODOS: Foi realizada uma revisão de literatura sistemática e os achados foram apresentados de acordo com estudos clínicos e de neuroimagem, e de acordo com o tipo de tarefa em questão. RESULTADOS: A literatura apresentou estudos diversificados sobre o assunto, com diferentes objetivos, metodologias e populações. Após análise dos dados (com critérios de exclusão) dos estudos obtidos na busca, apenas 40 estudos foram incluídos nesta revisão. CONCLUSÃO: Foi possível concluir que FA e NA envolvem diferentes áreas cerebrais, embora envolvam áreas e circuitos frontais, outras áreas também são críticas. Tais tarefas podem ser importantes na diferenciação das Afasias Progressivas Primárias; a FA pode ser uma nova medida de funções executivas; e, finalmente, ambos podem ser usados para permitir um melhor entendimento de processos cognitivos e de determinadas doenças.

Logopenic aphasia or Alzheimer's disease: Different phases of the same disease?

The logopenic variant of Primary Progressive Aphasia, or logopenic aphasia, is a the most recently described variant of Primary Progressive Aphasia and also the least well defined. This variant can present clinical findings that are also common to Alzheimer's disease, given they both share the same cytopathologic findings. This article reports the clinical case of a patient for whom it proved difficult to define a clinical diagnosis, being split between the logopenic variant and Alzheimer's disease at different phases of the disease. Using this case as an example and drawing on the latest evidence from the literature on the logopenic variant, we postulate the hypothesis that this variant may present as an initial symptom of Alzheimer's disease in some atypical cases.

A variante logopênica da Afasia Progressiva Primária, ou afasia logopênica, é a variante mais recentemente descrita entre todas as variantes da Afasia Progressiva Primária e, também por isso, a menos definida. Essa variante pode apresentar achados clínicos em comum com a doença de Alzheimer pelo fato de compartilharem o mesmo achado citopatológico. Este artigo descreve o caso clínico de uma paciente na qual se evidenciou uma dificuldade em assumir o diagnóstico clínico que se dividia entre a variante logopênica e a doença de Alzheimer em determinadas fases da doença. Utilizando este caso como exemplo e as atuais evidências que a literatura apresenta sobre a variante logopênica, levantamos a hipótese de que essa variante pode apresentar-se como uma manifestação inicial da doença de Alzheimer em alguns casos menos típicos.

Evaluation of patients with behavioral and cognitive complaints: misdiagnosis in frontotemporal dementia and Alzheimer's disease.

BACKGROUND: Frontotemporal dementia (FTD) is a heterogeneous clinicopathological syndrome whose early diagnosis is critical for developing management strategies. OBJECTIVE: To analyze the variables associated with misdiagnosis in a group of patients with FTD, Alzheimer's disease (AD), and without neurodegenerative disorders (WND), all of whom were evaluated for behavioral and cognitive complaints. METHODS: A case-control study with FTD (n=10), probable AD (n=10) and WND (n=10) patients was carried out. The studied variables were disease duration, reason for referral, former diagnosis, behavioral and cognitive symptoms at evaluation, MMSE at the specialist evaluation, and follow-up outcome. The data were analyzed by ANOVA with Bonferroni post-hoc and by Pearson's Chi-Square tests. RESULTS: FTD patients and WND patients showed longer disease duration than AD patients; the main reasons for referral in the FTD group were behavioral, memory and memory plus language problems while all AD and 90% of the WND group were referred for memory. The FTD group had the highest rate of misdiagnosis and worst outcomes after the 12-month follow-up. The majority of AD and WND patients had memory symptoms, while FTD patients presented language (30%), memory and/or language (40%) problems on the evaluation. CONCLUSION: Difficulty in recognizing the main features of FTD and psychiatric disorders with memory impairment was observed. Clinicians tended to generalize memory complaints toward a single diagnosis, identifying almost all these patients as AD or leaving them undiagnosed.

INTRODUÇÃO: Demência frontotemporal (DFT) é uma síndrome clinicopatológica heterogênea e seu diagnóstico precoce é essencial para o desenvolvimento de estratégias de manejo. OBJETIVO: Analisar as variáveis associadas ao erro dignóstico em pacientes com DFT, doença de Alzheimer (DA) e sem transtornos neurodegenerativos (STN), avaliados por queixas cognitivas e comportamentais. MÉTODOS: Estudo de caso-controle foi realizado com pacientes com DFT (n=10), provável DA (n=10), e STN (n=10). As variáveis estudadas foram duração da doença, motivo do encaminhamento, diagnóstico prévio, sintomas cognitivos e comportamentais na avaliação especializada, MEEM na avaliação, e desfecho. As análises foram feitas por ANOVA com Bonferroni post-hoc e Qui-Quadrado de Pearson. RESULTADOS: Pacientes com DFT e STN mostraram maior tempo de duração da doença; os principais motivos de encaminhamento no grupo DFT foram problemas comportamentais, memória e memória mais linguagem, enquanto em todos pacientes com DA e 90% do grupo STN foi memória. O grupo DFT teve maiores taxas de erro diagnóstico e piores desfechos no seguimento de 12 meses. A maioria dos pacientes com DA e STN teve sintomas de memória, enquanto pacientes com DFT apresentaram sintomas de linguagem (30%), memória e/ou linguagem (40%) na avaliação. CONCLUSÃO: Dificuldade em reconhecer as principais características da DFT e de transtornos psiquiátricos com prejuízo de memória foi observada. Os clínicos tenderam a generalizar queixas de memória em direção a um único diagnóstico, identificando quase todos estes pacientes como tendo DA ou deixando-os sem diagnóstico.

Dietary aspects of migraine trigger factors.

The significance of dietary factors as triggers for migraines is controversial, and the assessment of this topic is complex and inconclusive. In order to evaluate the published evidence on dietary triggers, a critical review of the literature was performed by conducting a search for food item descriptors linked to migraines in the PubMed and SciELO databases. Reviews and relevant references cited within the articles that resulted from the search were also included. Of the 45 studies reviewed, 16 were population studies that involved the association between migraines and eating habits or the prevalence of related dietary factors; 12 involved interventions or analyzed observational prospective cohorts; and 17 were retrospective studies. Approximately 30 dietary triggers were explored in total, although only seven of these were addressed experimentally. In the prospective studies, patients were instructed to keep a diary; two of these studies involved dietary interventions. Conclusions that are based on nonpharmacological prophylactic strategies with a scientific basis and that show an association between certain dietary factors and the triggering of migraines are limited by the lack of prospective studies with clear experimental designs. Nevertheless, the high frequency of possible specific dietary triggers validates efforts to elucidate the involvement of food-related factors in precipitating migraines.

Cognitive, functional and behavioral assessment: Alzheimer's disease.

A review of the evidence on cognitive, functional and behavioral assessment for the diagnosis of dementia due to Alzheimer's disease (AD) is presented with revision and broadening of the recommendations on the use of tests and batteries in Brazil for the diagnosis of dementia due to AD. A systematic review of the literature (MEDLINE, LILACS and SCIELO database) was carried out by a panel of experts. Studies on the validation and/or adaptation of tests, scales and batteries for the Brazilian population were analyzed and classified according to level of evidence. There were sufficient data to recommend the IQCODE, DAFS-R, DAD, ADL-Q and Bayer scale for the evaluation of instrumental activities of daily living, and the Katz scale for the assessment of basic activities of daily living. For the evaluation of neuropsychiatric symptoms, the Neuropsychiatric Inventory (NPI) and the CAMDEX were found to be useful, as was the Cornell scale for depression in dementia. The Mini-Mental State Examination has clinical utility as a screening test, as do the multifunctional batteries (CAMCOG-R, ADAS-COG, CERAD and MDRS) for brief evaluations of several cognitive domains. There was sufficient evidence to recommend the CDR scale for clinical and severity assessment of dementia. Tests for Brazilian Portuguese are recommended by cognitive domain based on available data.

Este artigo apresenta revisão e ampliação das recomendações sobre os testes e baterias empregados no Brasil para o diagnóstico e avaliação cognitiva, funcional e comportamental da demência na doença de Alzheimer (DA). De modo sistemático foi revista a literatura disponível (nas bases MEDLINE, LILACS e SCIELO) e os artigos foram avaliados e classificados por níveis de evidência, para se estabelecerem as recomendações. Para a avaliação funcional a recomendação é o uso das escalas IQCODE, DAFS-R, DAD, ADL-Q e Bayer para avaliação das atividades instrumentais da vida diária e escala Katz para avaliação das atividades básicas. Para avaliação dos sintomas neuropsiquiátricos foram recomendadas as escalas NPI e CAMDEX e a Cornell para depressão em demência. Como instrumento de rastreio deve-se utilizar o Mini-Exame do Estado Mental; quanto às baterias multifuncionais, pode-se aplicar CAMCOG-R, ADAS-COG, CERAD e MDRS, que avaliam brevemente várias funções cognitivas. Para avaliação clínica da demência e classificação de acordo com a gravidade é recomendada a escala CDR. São recomendados os testes por domínio cognitivo baseados nas evidências disponíveis para uso na nossa língua.

Body mass index, cognitive deficit and depressive symptoms in high cardiovascular risk patients.

To evaluate the relationship of obesity, cognitive impairment and depressive symptoms in patients with high cardiovascular risk. METHODS: A sample of 93 patients aged 50 years or older was selected from the Center of Dyslipidemia and High Cardiovascular Risk from Hospital de Clínicas de Porto Alegre (HCPA). Patients with stroke were excluded. For cognitive evaluation, the MMSE (Mini Mental State Examination) was used. A score of 24 or less was considered as cognitive impairment, and for those who had 4 years or less of education, the cutoff point was 17. The GDS-15 (Geriatric Depression Scale) was also used, with the cutoff of 6 for presence of depressive symptoms. RESULTS: Obese patients showed lower mean MMSE scores compared to non-obese patients (p=0.0012). Additionally, for every one point increase in BMI above 30 there was a 27% increase in the chances of the patient having cognitive impairment. The obese patients presented 31% chance of having cognitive impairment compared with overweight subjects. CONCLUSIONS: Our findings corroborated the association between obesity and cognitive impairment in high cardiovascular risk patients. This association however, was not observed for depressive symptoms.

Avaliar a associação entre obesidade, comprometimento cognitivo e sintomas depressivos em pacientes de alto risco cardiovascular. MÉTODOS: Foi selecionada uma amostra de 93 pacientes com 50 anos ou mais em acompanhamento no Centro de Dislipidemia e Alto Risco Cardiovascular do Hospital de Clínicas de Porto Alegre (HCPA). Pacientes com história de acidente vascular cerebral (AVC) foram excluídos. Para a avaliação cognitiva, foi utilizado o MEEM (Mini Exame do Estado Mental). Escores de 24 ou menos foram considerados como comprometimento cognitivo, para pacientes com 4 ou menos anos de escolaridade, o ponto de corte usado foi de 17 pontos. A escala GDS-15 (Geriatric Depression Scale) também foi utilizada, sendo adotado o ponto de corte 6 para a presença de sintomas depressivos. RESULTADOS: Pacientes obesos apresentaram valores menores na média dos escores do MEEM quando comparados a pacientes não-obesos (p=0,0012). Além disso, para cada ponto de acréscimo no IMC acima de 30, houve um aumento de 27% na chance do paciente ter comprometimento cognitivo. Os pacientes obesos apresentaram 31% de chance de ter comprometimento cognitivo quando comparados com pacientes com sobrepeso. CONCLUSÕES: Os achados do presente estudo corroboram a associação entre obesidade e comprometimento cognitivo em pacientes de alto risco cardiovascular. Entretanto, esta associação não foi observada ao se analisar os sintomas depressivos.

The Basis and Applications of the Action Fluency and Action Naming Tasks / Bases e Aplicações dos Testes Fluência de Ações e Nomeação de Ações

The Action Fluency (AF) and Action Naming (AN) are different tasks involving verb generation. Evidence indicates that verb tasks yield different information from that obtained with nouns. OBJECTIVE: This study aimed to analyze the information available in the scientific literature on the mechanism and clinical application of these tasks. METHODS: We carried out a systematic review of the literature and the findings were presented according to clinical studies and neuroimaging studies, and to the task in question. RESULTS: The literature contained a variety of relevant studies with different objectives, methodologies and populations. After the analysis (exclusion criteria) of the studies obtained by the search terms, only 40 studies were included in this review. CONCLUSION: It was possible to conclude that AF and AN involve different brain processes, and although recruiting frontal areas and circuits, other areas are also critical. These tasks may be useful for differentiating Primary Progressive Aphasias; AF might represent a new measure of executive function; finally, both these tests can be used to provide a better understanding of cognitive processes and certain diseases.

A Fluência de Ações (FA) e a Nomeação de Ações (NA) são diferentes tarefas que exigem geração de verbos. Evidências indicam que tarefas que utilizam verbos fornecem informações diferentes daquelas que utilizam substantivos. OBJETIVO: Este estudo objetivou analisar a informação disponível na literatura científica sobre mecanismos e aplicações clínicas destas tarefas. MÉTODOS: Foi realizada uma revisão de literatura sistemática e os achados foram apresentados de acordo com estudos clínicos e de neuroimagem, e de acordo com o tipo de tarefa em questão. RESULTADOS: A literatura apresentou estudos diversificados sobre o assunto, com diferentes objetivos, metodologias e populações. Após análise dos dados (com critérios de exclusão) dos estudos obtidos na busca, apenas 40 estudos foram incluídos nesta revisão. CONCLUSÃO: Foi possível concluir que FA e NA envolvem diferentes áreas cerebrais, embora envolvam áreas e circuitos frontais, outras áreas também são críticas. Tais tarefas podem ser importantes na diferenciação das Afasias Progressivas Primárias; a FA pode ser uma nova medida de funções executivas; e, finalmente, ambos podem ser usados para permitir um melhor entendimento de processos cognitivos e de determinadas doenças.